CRA International Inc
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at CRA International Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 137.80 $ to 223.30 $ · Last price: 166.40 $ (As of: September 17, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Consulting Services
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| CRA International Inc CRAI | 1.1 | 23.4 | 12.1 | 29.0 | – | 9.3 | -18.3 |
| Verisk Analytics Inc VRSK | 22.4 | 27.2 | 16.9 | 70.2 | 45.0 | 6.6 | -28.6 |
| Equifax Inc EFX | 19.6 | 29.7 | 13.4 | 55.5 | 17.5 | 6.9 | -37.9 |
| Booz Allen Hamilton Holding BAH | 9.5 | 11.8 | 10.4 | 22.4 | 9.5 | -6.4 | -20.0 |
| FTI Consulting Inc FCN | 4.3 | 16.8 | 11.8 | 31.8 | 8.5 | 2.4 | -13.5 |
| Huron Consulting Group Inc HURN | 2.6 | 26.4 | 14.1 | 32.7 | 9.3 | 14.3 | 11.3 |
| ICF International Inc ICFI | 1.5 | – | 11.0 | 37.2 | – | -7.3 | -9.6 |
| Roma Green Finance Limited ROMA | 0.5 | – | 0.0 | 8.9 | -194.8 | -21.9 | 183.4 |
| SBC Medical Group Holdings Incorporated SBC | 0.5 | 12.2 | 4.1 | 71.9 | – | -15.5 | 2.9 |
| Median of companies shown | 2.6 | 23.4 | 11.8 | 32.7 | 9.4 | 2.4 | -13.5 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 325 | 19 | 13 | 1.50 | 48 | 208 | 324 |
| 2017 | 370 | 16 | 8 | 0.90 | 46 | 207 | 362 |
| 2018 | 418 | 29 | 22 | 2.62 | 36 | 196 | 371 |
| 2019 | 451 | 29 | 21 | 2.54 | 28 | 198 | 533 |
| 2020 | 508 | 35 | 25 | 3.08 | 55 | 209 | 559 |
| 2021 | 566 | 56 | 42 | 5.47 | 76 | 206 | 555 |
| 2022 | 591 | 59 | 44 | 5.93 | 25 | 211 | 551 |
| 2023 | 624 | 57 | 38 | 5.41 | 60 | 212 | 553 |
| 2024 | 687 | 71 | 47 | 6.75 | 50 | 212 | 571 |
| 2025 | 752 | 83 | 55 | 8.16 | 22 | 214 | 629 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 2.18 | 34.40 | 176 | 9.20 | 8.50 | 79 | 69 |
| 2025: Q1 | 2.62 | 34.30 | 182 | 5.90 | 9.90 | -80 | -81 |
| 2025: Q2 | 1.80 | 89.70 | 187 | 9.00 | 6.50 | 6 | 5 |
| 2025: Q3 | 1.73 | 3.70 | 186 | 10.80 | 6.20 | 37 | 36 |
| 2025: Q4 | 1.99 | -8.90 | 197 | 11.60 | 6.70 | 60 | 59 |
| 2026: Q1 | 1.69 | -35.60 | 201 | 10.50 | 5.50 | -114 | -117 |
| 2026: Q2 | – | – | 211 | 12.80 | 6.40 | -4 | -6 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 12 of our scanner strategies — each hit links to the scanner.
Backtested Scanners
Quality & Balance Sheet
Aktien.Guide
Breakout & Setup
Dividends
Momentum & Trend
Risk & Weakness
- Below the 50- & 200-SMA
- Near 52-Week Low
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Weakness Cluster
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 8.47 | 8.21 – 8.77 | 814 | 2.9% | 3 |
| 12/31/2027 | 9.56 | 8.93 – 10.16 | 847 | 12.9% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available.
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 8.4%
- More than 10% revenue growth is expected for the coming year 4.6%
- Share count grows by less than 3% a year -3.0%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 11.8%
- Gross margin at 40% or higher and without meaningful erosion 29.0%
- Goodwill from acquisitions does not grow faster than revenue 15.1%
- Net debt below twice EBITDA 1.1 x EBITDA
- Operating cash flow covers the profits of the last three years -8 m
- Return on capital at 15% or higher, or up versus two years ago 27.8%
- Insiders hold at least 10% or are net buyers 3.7%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
10/10 Quality stockThe AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 9.8%
- Exp. sales growth 3Y > 5% 6.2%
- EBIT growth 10Y > 5% 17.9%
- Exp. EBIT growth 3Y > 5% 8.3%
- Net debt < 4x EBIT 1.3x
- EBIT positive, 10Y straight 10
- Max. EBIT decline < 50% 16.7%
- Return on equity > 15% 48.4%
- ROCE > 15% 27.8%
- Expected return > 10% 10.2%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 31, 2026 | Maleh Paul A | PRESIDENT AND CEO | Sell | 32 | 174.78 | 5,593 |
| Aug 31, 2026 | Maleh Paul A | PRESIDENT AND CEO | Sell | 268 | 174.13 | 46,666 |
| Aug 31, 2026 | Maleh Paul A | PRESIDENT AND CEO | Sell | 4,852 | 173.04 | 839,596 |
| Aug 31, 2026 | Maleh Paul A | PRESIDENT AND CEO | Sell | 2,348 | 172.06 | 403,994 |
| Aug 25, 2026 | Yellin Jonathan D | EVP AND GENERAL COUNSEL | Sell | 400 | 174.26 | 69,704 |
| Aug 25, 2026 | Yellin Jonathan D | EVP AND GENERAL COUNSEL | Sell | 1,307 | 173.34 | 226,549 |
| Aug 25, 2026 | Yellin Jonathan D | EVP AND GENERAL COUNSEL | Sell | 543 | 172.30 | 93,561 |
| Aug 4, 2026 | Langan Brian | See Remarks | Other | 54 | 180.05 | 9,723 |
| Aug 4, 2026 | Langan Brian | See Remarks | Other | 2 | 180.85 | 362 |
| Aug 4, 2026 | Langan Brian | See Remarks | Other | 185 | – | – |
The company
About the Company
CRA International, Inc. bietet zusammen mit seinen Tochtergesellschaften weltweit Wirtschafts-, Finanz- und Managementberatungsdienstleistungen an.
- Employees
- 968
- Headquarters
- Boston, MA
- Address
- 200 Clarendon Street, 02116-5092 Boston, United States
- Phone
- 617 425 3000
- Website
- crai.com
- IPO Date
- 04/24/1998
- ISIN
- US12618T1051
Management
| Name | Title | Birth Year |
|---|---|---|
| Paul A. Maleh | Chairman, President & CEO | 1964 |
| Eric R. Nierenberg Ph.D. | Executive VP, CFO & Treasurer | 1975 |
| Jonathan D. Yellin J.D. | Executive VP, General Counsel & Secretary | 1964 |
| Chad Holmes | Executive VP & Chief Corporate Development Officer | 1973 |
| Brian Langan | Executive VP, Chief Strategy & Business Transformation Officer | 1980 |
| Mary Beth Savio | VP & Director of Operations | – |
| Sandra A. David | VP, Chief Accounting Officer & Controller | – |
| Graham Ross | VP & Global Chief Marketing Officer | – |
| Elahd Toam | Principal | – |
| Miguel Herce | Principal | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.